COVID-19 Update

As the global impacts of COVID-19 evolve, Novocure® is taking proactive steps to protect and support the health and well-being of our colleagues, our patients and caregivers, and all of our partners, while we continue to deliver our therapy to patients in need. Learn more.

Treatment for glioblastoma (GBM)
This site is intended for US healthcare professionals only.

Calendar of events

August 13, 2020

August night-time Webinar

OptuneOpenHouse.com

7:00 PM EST

To RSVP, call 1-844-247-1636

August 27, 2020

August day-time webinar

OptuneOpenHouse.com

12:00 PM EST

To RSVP, call 1-844-247-1636

Indications For Use

Optune is intended as a treatment for adult patients (22 years of age or older) with histologically-confirmed glioblastoma multiforme (GBM).